NCT06867198Recruiting
Peanuts for Cardiometabolic, Brain, and Intestinal Health
Impact of Peanuts on Cardiometabolic, Cognitive, and Intestinal Health in Prediabetes Among Racially Diverse Populations
Source: ClinicalTrials.gov · Last updated 2 Sept 2026
Brief summary (registry, in English)
The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- First submitted
- 4 Mar 2025
- Start date
- 6 Mar 2025
- Primary completion date
- Sept 2027
- Lead sponsor
- Georgia State University
- Diseases
- Type 2 diabetes
- NCT number
- NCT06867198
What you commit to
- Study type: Interventional
- Planned participants: 72
- From 6 Mar 2025 to the primary completion date, Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs
Other illness
- Allergies to peanuts and peanut products
- Active cancer, gastrointestinal, renal, cardiovascular, thyroid, and neurological diseases or severe head injury
- Certain neurological disorders (e.g., uncontrolled seizure disorders)
- Braces on their teeth, a cardiac pacemaker; hearing aid; other metal in the body or eyes (which may include certain metallic-embedded tattoos), including but not limited to pins, screws, shrapnel, plates, dentures or other metal objects
Other
- Smoking
- Consumes greater than 2 alcoholic beverages per day
- Consumes antioxidant, probiotic, and prebiotic supplements
- Pregnant or Lactating
- Actively participating in a weight loss program
- MRI Exclusion Criteria:
Who the study is looking for
- men and women
- 20-59 years of age
- BMI: 24.5 - 35.5 kg/m\^2
- Prediabetes (fasting blood glucose levels 100-125 mg/dL and/or HbA1c between 5.7-6.4%)
- Ability to give consent
Age in the registry: 20 years to 59 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Georgia State University Coordinator of this site? Confirm its status | Atlanta | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.